The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Kenya’s military chief dies in a helicopter crash
Xi plants trees in Beijing, urging nationwide afforestation efforts for beautiful China
China launches new remote sensing satellite
NetEase Inc renews game partnership with Blizzard
At least 37 mothers killed daily in Gaza: medics
Connor McDavid becomes 4th in NHL history with 100 assists as the Oilers rout the Sharks 9
China unveils regulations on implementation of consumer rights protection law
Meta's newest AI model beats some peers. But its amped
Overseas hanfu clubs serve as cultural ambassadors